Knowing More Matters
Is it COVID-19, RSV,
or the Flu?
About Respiratory Illnesses: COVID-19, RSV infection, and influenza
While impacting people of all ages, the viruses causing COVID-19, RSV disease, and the flu render the following populations especially vulnerable: children, the elderly, those who are immunocompromised, and people with underlying conditions. Coughing, sneezing, and potential contact with virus-contaminated surfaces all contribute to virus spread.
Look for these Symptoms
Often spiking during the winter season, COVID-19, RSV disease and the flu are contagious respiratory illnesses that share many of the same symptoms. The three illnesses could possibly seasonally surge, posing a triple threat to you and your family. Here’s how symptoms overlap:
More than 96 million people in the U.S. have suffered from COVID-19.
More than 5.4 million have been hospitalized.
More than 1,058,692 have died.
On average, more than 2 million people suffer from RSV disease each year.
On average, more than 235,000 are hospitalized each year.
On average, more than 14,000 die each year.
More than 35 million people in the US suffered from flu-related illness from 2019–2020.
More than 380,000 million were hospitalized between 2019–2020.
More than 20,000 died between 2019–2020.
Solution: Multiplex Test
As we face respiratory season, clarity in distinguishing between respiratory illnesses is paramount. A PCR multiplex test will empower your provider to detect and differentiate between COVID-19, Flu A, Flu B, and RSV with a single nasal swab. PCRplus multiplex tests are designed for COVID-19 detection and broader coverage for variants.
PCRplus is an elevated category of PCR testing because it combines the following five advantages:
Results you can rely on.
Don’t wait days. Same-day results.
Results anytime, anywhere.
A track record of results you can trust.
Easy steps from test to result.
Time to results and intended use environment may vary, refer to individual test package insert for details.
COVID-19 – Centers for Disease Control and Prevention (January 4, 2022). Symptoms of COVID-19, “Watch for Symptoms.” Retrieved from: https://www.cdc.gov/coronavirus/2019- ncov/symptoms-testing/symptoms.html
RSV – Centers for Disease Control and Prevention (January 4, 2022). Symptoms and Care, “Symptoms.” Retrieved from: https://www.cdc.gov/rsv/about/symptoms.html
Flu – Centers for Disease Control and Prevention (January 4, 2022). Flu Symptoms & Complications, “Flu Symptoms.” Retrieved from: https://www.cdc.gov/flu/symptoms/ symptoms.htm
Centers for Disease Control (October 20, 2022). Covid Data Tracker Weekly Review. Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html
Centers for Disease Control and Prevention (December 18, 2020). Respiratory Syncytial Virus Infection (RSV), Trends and Surveillance. Retrieved from: https://www.cdc.gov/rsv/ research/us-surveillance.html
Centers for Disease Control and Prevention (October 1, 2021). Estimated Flu-Related Illnesses, Medical visits, Hospitalizations, and Deaths in the United States — 2019–2020 Flu Season. Retrieved from: https://www.cdc.gov/flu/about/burden/2019-2020. html#estimates
For more information about COVID-19, RSV and flu, please visit www.cdc.gov. For use under an Emergency Use Authorization in the United States